Prostate Cancer. Malignant neoplasm of prostate
Conditions
Interventions
Intervention 1: Intervention group: Patients will undergo antibiotic therapy (Ciprofloxacin tablets 500 mg every 12 hours for 4 weeks). Intervention 2: Control group: Patients won't undergo any medica
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients older than 40 years of age with prostate-specific antigen (PSA) in the range of 4-15 ng/ml Patients with normal digital rectal examination (DRE) Patients without Irritative and obstructive urinary symptoms Patients with informed consent
Exclusion criteria
Exclusion criteria: Patients undergoing rectal biopsy (TRUS) during the past month. Patients who have ejaculation in the past 28 hours. Patients who have undergone urological surgeries during the past six months. Patients with a history of prostate cancer or clinical and laboratory evidence Patients with a history of taking 5-alpha-blockers such as Finasteride in the past six weeks
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Biopsy results. Timepoint: One month after referring to the specialist. Method of measurement: Standard biopsy (12-core). | — |
Primary
| Measure | Time frame |
|---|---|
| PSA levels above 4 ng / ml. Timepoint: One month after referring to the specialist. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHadi Maleki
Yazd University of Medical Sciences
Outcome results
None listed